Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Longeveron Inc. LGVN
$3.31
-$0.13 (-4.06%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
87993176.00000000
-
week52high
9.34
-
week52low
2.50
-
Revenue
1222000
-
P/E TTM
-3
-
Beta
0.55258500
-
EPS
-0.89000000
-
Last Dividend
0.00000000
-
Next Earnings Date
14 мая 2021 г. в 10:59
Описание компании
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Buy | 24 мар 2022 г. | |
| EF Hutton | Buy | 05 янв 2022 г. | |
| EF Hutton | Buy | Buy | 10 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Hare Joshua | D | 7793263 | 20000 | 27 янв 2023 г. |
| Clavijo James | D | 75649 | 1288 | 03 янв 2023 г. |
| Lehr Paul T | D | 147042 | 1472 | 03 янв 2023 г. |
| Girolamo Todd C | A | 5000 | 5000 | 21 дек 2022 г. |
| Soffer Donald M | A | 5000 | 5000 | 21 дек 2022 г. |
| Ungaro Ursula | A | 5000 | 5000 | 21 дек 2022 г. |
| LOSORDO DOUGLAS W | A | 5000 | 5000 | 21 дек 2022 г. |
| Hare Joshua | A | 5000 | 5000 | 21 дек 2022 г. |
| Ross Cathy | A | 5000 | 5000 | 21 дек 2022 г. |
| Soffer Rock | A | 5000 | 5000 | 21 дек 2022 г. |
Новостная лента
3 Penny Stocks That Could Rise 500% in 2023
InvestorPlace
13 янв 2023 г. в 11:37
In November 2021, I made an outlandish effort to pick 5 cheap stocks that could double within a month. Few companies rise 100%, and even fewer can do it in the time it takes to properly pickle a cucumber.
Longeveron to Participate in Upcoming 2022 Investor Conferences
GlobeNewsWire
29 ноя 2022 г. в 16:30
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that Company leadership will participate in three upcoming investor conferences.
Longeveron Inc. (LGVN) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 10:39
Longeveron Inc. (NASDAQ:LGVN ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Representatives Dr. Chris Min - Interim Chief Executive Officer, Chief Medical Officer Dr. Joshua Hare - Co-Founder, Chief Science Officer, Chairman James Clavijo - Chief Financial Officer Elsie Yau - Stern Investor Relations Conference Call Participants Michael Okunewitch - Maxim Group Operator Good morning or good afternoon, and welcome to the Longeveron Inc., 2022 Third Quarter Earnings Call. My name is Ajay and I will be your operator today.
Longeveron to Announce Third Quarter 2022 Financial Results on November 14, 2022
GlobeNewsWire
07 ноя 2022 г. в 09:06
Live conference call on Monday, November 14 at 8:30 a.m. EST Live conference call on Monday, November 14 at 8:30 a.m. EST
Longeveron to Present at the Annual Dawson James Small Cap Growth Conference
GlobeNewsWire
05 окт 2022 г. в 08:30
MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming Dawson James Small Cap Growth Conference taking place in Jupiter, Florida from October 11-12, 2022.